Stroke 2025 | Neurology | Neurological Disorders | Paris | France | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

"Brain Health and Stroke: A Lifespan Approach"

- Stroke 2025

Welcome Message

14th International Conference on Neurological Disorders and Stroke
November 17–18, 2025 | Paris, France | Hybrid Event

We are delighted to announce that the 14th International Conference on Neurological Disorders and Stroke will be held in Paris, France, from November 17–18, 2025, as a hybrid event offering both in-person and virtual participation.

This international conference will serve as a vital platform for professionals dedicated to the study and treatment of neurological disorders and stroke. By bringing together distinguished academics, clinicians, researchers, and healthcare professionals from around the world, the event aims to foster meaningful dialogue, share recent advancements, and encourage international collaboration in this critical field.

The Stroke 2025 conference in Paris promises to deliver a rich scientific program, including high-quality keynote lectures, speaker sessions, and opportunities for knowledge exchange. We are especially committed to creating an inclusive environment where both experienced experts and emerging voices in neurology can engage, contribute, and learn.

On behalf of the Organizing Committee, it is our honour to invite you to be part of this important event. We look forward to welcoming you to Paris for an enriching and memorable experience.

Warm regards,
Jessica Louis
Organizing Committee | Stroke 2025

Scientific Sessions

Scientific tracks

Neurological Disorders
Neurology
Neuroscience
Stroke
Ischemic Stroke
Dementia
Epilepsy
Psychiatry
Amyloidosis
Animal Models Testing
Guillain Barre Syndrome
Parkinson’s Diseases
Alzheimer's Disease
Neuroimaging And Neurosonology
Neurodegenerative Disorders
Cerebrovascular Disease
Neonatal And Pediatric Stroke
Cognitive Impairment
Demyelinating Disease
Movement Disorders
Pediatric Neurology
Neurotherapy
Psychology

Session on Neurological Disorders

Diseases of the central and peripheral nervous systems are considered neurological disorders. These conditions include neurological problems as a result of malnutrition, epilepsy, Alzheimer's disease, and other dementias, cerebrovascular diseases such as stroke, migraine, and other headache disorders, multiple sclerosis, Parkinson's disease, neuro infections, and brain tumors.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neurology

In 2020, the size of the worldwide neuroscience market was $36.5 billion. Looking ahead, IMARC Group projects that the market will increase at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2028, reaching $46.2 billion by 2031. Neurology is a rapidly evolving field, with ongoing research and development of new treatments and therapies. Advances in neuroscience and technology have led to an improved understanding of the brain and nervous system, and opened up new avenues for the diagnosis and treatment of neurological disorders.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neuro Science

Modern Neuroscience has several branches, such as affective neuroscience, behavioral neuroscience, cellular neuroscience, clinical neuroscience, cognitive neuroscience, cultural neuroscience, molecular neuroscience, and social neuroscience.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Stroke

In recent days, so many people have been affected by Stroke, including infants. The stroke management market is divided into hospitals, diagnostic centres, outpatient surgical centres, and others. In 2021, the hospital sector has a market share of nearly 42 percent. Too many individuals lose their lives to strokes. How to prevent stroke, types of strokes, and other disorders can be elaborated through the Stroke 2023. The types of strokes are Brain stroke, pediatric stroke, Neonatal stroke, and Ischemic stroke.

Related conference:

Related associations:

Related Journals:

Related Societies:

Session on Ischemic stroke

Ischemic stroke is also called brain stroke. Because when the blood flow to a portion of the brain is blocked or diminished, brain tissue cannot get oxygen and nutrients, which results in an ischemic stroke. In minutes, brain cells start to degenerate. In recent years so many people have been affected by Ischemic stroke due to a lack of blood supply in the brain.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Dementia

Dementia is a type of Neurological Disorder, It is a set of symptoms that substantially affect memory, thinking, and social abilities and are referred to as dementia when they significantly interfere with day-to-day functioning. Numerous conditions can cause dementia, even if there isn't one specific sickness that does.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Epilepsy

Epilepsy is one of the Neurological disorders that cause seizures or periods of unusual behavior, abnormal brain activity sensations, and sometimes loss of awareness. Both men and women in all ethnic groups are affected by epilepsy. According to data from the World Health Organization, the average cost of healthcare per person globally in 2018 was USD 1,154.731. The cost of healthcare per person globally went from USD 784.313 in 2010 to USD 1,320.841 in 2019, with the United States as the top payer at USD 11,643.85 per capita in 2019.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Psychiatry

In the field of medicine known as psychiatry, mental, emotional, and behavioral problems are identified, treated, and prevented. A psychiatrist is a medical specialist who focuses on mental health, notably substance use disorders.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Amyloidosis

The market for treatments for transthyretin amyloidosis was valued at USD 4.822 billion in 2020 and is projected to grow to USD 7.11 billion by 2025. The size of the worldwide market for amyloidosis treatments was estimated at USD 3.7 billion in 2018 and is projected to grow at a CAGR of 6.9% during the forecast period. Some of the reasons that will jointly drive the market are the expanding elderly population, the increased acceptance of innovative targeted treatments and transplantation, the introduction of biologics, and these.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Animal Models Testing

In recent years Animal models Testing was such a trending topic in Neurology. The market for animal models was valued at USD 17.27 billion in 2019 and is anticipated to rise to USD 29.08 billion by 2025, at a CAGR of 10.29%. Neuroscience, pharmacology, toxicology, and genetics are just a few of the scientific areas that employ animal models. Animals including mice, rats, rabbits, dogs, and non-human primates are frequently utilized as models those will be briefly elaborated in Stroke Conference.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Guillain-Barre Syndrome

Peripheral nervous system disease called Guillain-Barre syndrome. During the projection period, 2021-2026, the Guillain-Barre Syndrome Market Study is expected to expand at a CAGR of 4.9%. The COVID-19 virus has a substantial effect on the market for Guillain-Barre syndrome (GBS) treatments.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Parkinson’s Diseases

Tremors, stiffness, bradykinesia (slow movement), and postural instability are all signs of Parkinson's disease. Other symptoms may include a loss of smell, sleep disturbances, constipation, depression, and cognitive impairment. The market for medications for Parkinson's disease was estimated to be worth $5.9 billion globally in 2020; it is anticipated to increase to $11.2 billion by 2028, with a CAGR of 6.8% from 2020 to 2035. Parkinson's disease is a neurodegenerative condition commonly known as idiopathic Parkinsonism.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Alzheimer's Disease

Alzheimer's disease is a neurodegenerative disorder that affects the brain, causing a decline in cognitive function and memory loss. In older people, it is the most typical cause of dementia. The Global market rate for Alzheimer’s disease was estimated to be worth $4.3 billion in 2019 and $6.2 billion by 2023, with a CAGR of 6.3% during the period of 2019-2023.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neuroimaging and Neurosonology

Neuroimaging and neurosonology are both diagnostic tools used in the field of neurology to help visualize and study the structure and function of the brain and nervous system. Neuroimaging refers to a group of techniques used to create images of the brain and its structures. Neurosonolgy is one of the diagnostic tools that use ultrasound technology.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neurodegenerative Disorders

The market for neurodegenerative diseases was estimated to be worth USD 39,125 million in 2020, and it is anticipated to grow to USD 78,295 million by 2035, showing a CAGR of 6.2% during the projected period (2020–2035).

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Cerebrovascular Disease

Treatment for Cerebrovascular disease depends on the underlying condition and the severity of the symptoms. Medications may be used to help prevent blood clots and reduce the risk of stroke or TIA, and surgery or endovascular procedures may be necessary to repair damaged blood vessels or prevent further damage. Cerebrovascular disease knowledge was very important these are briefly elaborated on the Stroke 2023.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neonatal and Pediatric Stroke

For neonatal and pediatric stroke, respectively, the average adjusted 5-year expenditures are significant at $54,719 and $135,168. The average price of admission for a youngster with a stroke was $91,869. Neonatal stroke birth admission expenses were on average $49,633; when these prices were adjusted for control birth admission costs, the difference was just $5,792, indicating that the stroke was responsible for 87% of the expenditures.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Cognitive Impairment

Depending on the underlying reason, treatment for cognitive impairment may involve drugs to control symptoms, cognitive and behavioral therapy, lifestyle changes, and supportive care. Early detection and treatment of cognitive impairment are crucial because certain causes of it may be reversible if discovered and addressed quickly enough. The cognitive impairment will be explained in Stroke 2023.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Demyelinating Disease

The protective coating known as the myelin sheath, which covers nerve fibers in the central and peripheral nervous systems, is a structure that is harmed by a set of illnesses known as demyelinating diseases. Numerous symptoms, including muscular weakness, tingling or numbness in the limbs, issues with balance and coordination, as well as issues with vision and speech, can be brought on by these illnesses.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Movement Disorders

This market research study on the treatment of dementia and movement disorders offers insightful information on the market's response to COVID-19, which will assist businesses in assessing their strategic business plans. The researcher at Technavio projects that the market for treating dementia and mobility disorders would be worth USD 8.14 billion by 2030, growing at a CAGR of 7.95%.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Pediatric Neurology

A specialty of medicine called pediatric neurology is dedicated to identifying and treating neurological disorders in infants and children. Pediatric neurologists are medical professionals with specialized training in this area who are prepared to treat newborns, kids, and teenagers with neurological issues.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neurotherapy

Neurotherapy, also known as neurofeedback or EEG biofeedback, is a type of therapy that uses real-time feedback from the brain to help individuals learn to regulate and control their brainwave activity. The market for Neurotherapy is anticipated to reach $ 1,236.6 million in 2021 and grow at a CAGR of 7.4% from 2021 to 2027.

Related conference:

Related associations:

Related Societies:

Related Journals:

Market Analysis

Market Analysis 2025: Neurological Disorders and Stroke

Overview

Neurological disorders, including stroke, dementia, Parkinson’s disease, and multiple sclerosis, continue to pose a significant global health burden. The convergence of aging populations, increased awareness, technological advancements, and innovative treatment methods is driving substantial growth across several market segments. By 2025, the global market outlook reflects strong momentum, particularly in stroke management, neurology devices, and CNS disorder therapeutics.

1. Stroke Management Market

Market Size (2025): USD 66.87 billion
CAGR (2015–2025): 8.8%
Drivers:
- Rise in stroke incidence due to aging and lifestyle-related risk factors
- Adoption of advanced imaging and diagnostic tools
- Increasing awareness and government initiatives for early detection and intervention
Diagnostic Tools: CT scan, MRI, cerebral angiography, ultrasound, echocardiogram, blood tests
Common Stroke Types:
- Ischemic Stroke
- Hemorrhagic Stroke
- Transient Ischemic Attack (TIA)
Treatment Methods:
- Antiplatelets (e.g., aspirin)
- Anticoagulants
- Clot retrieval procedures
- Rehabilitation therapy

2. Neurology Devices Market

CAGR (2015–2025): 9.11%
Key Trends:
- Development of minimally invasive surgical tools
- AI and robotics in neurosurgery
- Remote monitoring devices for neurological assessments
COVID-19 Impact:
- Delays in elective surgeries and diagnostics
- Redirected healthcare resources limited non-emergency neurological services
- Growing demand post-pandemic due to deferred diagnosis and treatment

3. Medications for Neurological Disorders

Projected Market Size (2025): USD 156.60 billion
CAGR (2015–2025): 8.9%
Market Segments:
- Parkinson’s, Alzheimer’s, Epilepsy, Multiple Sclerosis, Huntington’s Disease
- Expansion of neuroprotective agents and symptomatic treatments
COVID-19 Disruption:
- WHO survey across 145 countries in June 2020:
  - 48% of nations experienced partial or full disruption in neurological care
  - Patients with chronic neurological illnesses more vulnerable to severe COVID outcomes

4. Central Nervous System (CNS) Therapeutics Market

Market Size (2030): USD 174.38 billion
Market Size (2020): USD 86.02 billion
CAGR (2020–2030): 8.9%
Opportunities:
- Biologics and targeted therapies
- Increasing clinical trials for neuroinflammation and neurodegeneration
- Use of digital therapeutics and personalized medicine

5. Ischemic Stroke Market

CAGR (2015–2030): 8.7%
Symptoms:
- Sudden onset of paralysis, vision loss, speech difficulties, vertigo, facial droop, mental status changes
Therapeutic Innovations:
- Thrombectomy devices
- Next-generation anticoagulants
- Neurorestorative therapies

6. Guillain-Barré Syndrome (GBS) Market

Market Size (2030): USD 608.62 million
CAGR (2022–2030): 5.20%
Market Factors:
- Rare but serious autoimmune neurological disorder
- Treatments include IVIG therapy and plasma exchange
- Challenges in diagnosis and delayed treatment access in low-resource settings

7. Neuroscience Market Outlook

CAGR (Forecast Period): 3.9%
Post-COVID Landscape:
- Rise in anxiety and depressive disorders
- Increased demand for mental health solutions
- More funding toward neuropsychological and psychiatric research
Highlight:
A 2021 study across 204 countries indicated a 25.5% rise in anxiety disorders in 2021 due to the pandemic pressuring healthcare systems to scale mental health services globally.

8. Global Neurological Burden & Future Outlook

WHO (2015): 15% of the global population affected by neurological disorders
UN (Latest Data): 7.8 million deaths annually from neurological diseases
Projection (2040): 125 million people may suffer from neurodegenerative diseases (currently 40 million)

Conclusion

The year 2025 marks a pivotal point in the neurological healthcare landscape. With robust CAGR rates across stroke management, neurology devices, CNS therapeutics, and diagnostics, the industry is on a growth trajectory driven by innovation, global collaboration, and digital transformation. Addressing treatment gaps and building resilient neurological care infrastructures particularly in response to long-term pandemic effects will remain top priorities for stakeholders worldwide.

About Conference

14th International Conference on Neurological Disorders and Stroke

November 17–18, 2025 | Paris, France | Hybrid Event

We are pleased to welcome you to the 14th International Conference on Neurological Disorders and Stroke, a two-day global event uniting the brightest minds in neurology, stroke care, and neuroscience research. This conference will focus on innovations that impact brain health across the lifespan from pediatric neurology to geriatric stroke care.

Conference Theme:

“Brain Health and Stroke: A Lifespan Approach”

This theme underscores the importance of brain wellness at every stage of life, highlighting personalized and age-specific approaches to neurological care, prevention, early diagnosis, treatment, and rehabilitation.

Scientific Focus:

The conference will emphasize comprehensive, precision-based strategies to advance the diagnosis, treatment, prognosis, and prevention of stroke and other neurological disorders. Key topics include:

Brain Development & Pediatric Neurology
Adult Stroke & Neurological Emergencies
Cognitive Decline & Neurodegeneration in Aging
Rehabilitation Technologies and Strategies
Neuroimaging, AI, and Predictive Analytics
Lifestyle, Prevention, and Population Health

Conference Format:

Hosted in Paris, France, with virtual access via Webex, this hybrid conference allows for global participation. All registered participants whether attending in person or online will have six months of access to all recorded sessions and handouts, ensuring no critical insight is missed.

Program Highlights:

Visionary Keynote Talks
Interactive Panels on clinical cases and emerging research
Oral Presentations, Poster Sessions, and Symposiums
Workshops, Video Demonstrations, and Live Q&A
Networking Lounges (both in-person and virtual)

Learning Objectives:

Participants will gain the ability to:

Apply evidence-based therapies and interventions across the neurological lifespan
Stay informed on the latest stroke and brain health research
Utilize modern technologies in diagnosis and patient care
Evaluate clinical outcomes and optimize multidisciplinary practices
Translate findings into practice for different age groups and populations

Why Attend?

Professional Development: Earn CME/CE credits
Global Networking: Build meaningful connections with peers and experts
Research Dissemination: Present and publish your latest work
Tech Showcase: Explore innovations in medical devices, diagnostics, and therapeutics
Flexible Access: Join in-person or remotely, with extended on-demand availability
Academic Visibility: Participate in journals and conference proceedings

Target Audience:

Neurologists & Neurosurgeons
Stroke Specialists & Rehabilitation Experts
Pediatric and Geriatric Neurology Practitioners
Researchers, Scientists & Clinical Investigators
Healthcare Providers & Policy Makers
Students, Residents, and Interns
Professors, Academic Institutions, and Universities
Healthcare Entrepreneurs and Tech Innovators
Medical Associations and Societies

Opportunities for Researchers:

Share your work through oral or poster sessions
Join specialized symposiums and expert panels
Publish in indexed conference proceedings or affiliated journals
Engage in scientific discussions with an interdisciplinary audience

We invite you to be part of Neurological Disorders and Stroke 2025, where we will collaboratively explore the future of brain health from early development to healthy aging shaping the next generation of neurological care.

Past Conference

Conference Report: 13th International Conference on Neurological Disorders and Stroke

June 20–21, 2024 | Dublin, Ireland

The 13th International Conference on Neurological Disorders and Stroke (Stroke 2024) was successfully held on June 20–21, 2024, in Dublin, Ireland, gathering a vibrant and diverse audience from across the globe. The event brought together esteemed professionals and thought leaders from the fields of neurology, neuroscience, and neurorehabilitation, all united in their mission to advance the understanding, diagnosis, and treatment of neurological conditions and stroke.

Theme:

"Innovations in Diagnostics, Treatments, and Rehabilitation of Neurological Diseases and Stroke"

The conference theme resonated deeply with attendees and inspired engaging discussions, knowledge sharing, and future collaborations. The sessions highlighted the latest research breakthroughs, clinical applications, and interdisciplinary approaches that are shaping the future of neurological care.

Global Participation and Networking:

The success of Stroke 2024 was driven by the international participation of researchers, clinicians, healthcare professionals, and academic experts. The event provided a valuable platform for professional networking, collaborative dialogue, and meaningful interaction among attendees from multiple specialties and regions.

Acknowledgements:

The Organizing Committee of Stroke 2024 extends its sincere appreciation to all attendees, speakers, and contributors who played a pivotal role in making the event a success. Special thanks are due to:

Dr. Randall Higashida, University of California, San Francisco, USA – for his invaluable support and coordination efforts.
Our distinguished keynote and special session speakers, whose contributions significantly enhanced the academic excellence of the event:

Keynote & Special Speakers:

Patricia A. Quigley | Nurse Consultant LLC | USA
Prof. Koji Abe | Okayama University | Japan
Dr. Si Ching Lim | Changi General Hospital | UK
Limin Yong | NTUC Health | Singapore
David Truswell | SomeFreshThinking LTD | UK
Dr. Hischam Bassiouni | Klinikum St. Marien Amberg | Germany
Veronica Franklin Gould | Arts4Dementia | UK
Dr. Andras Folyovich | Szent Janos Hospital | Hungary
Dr. Gibran Franzoni Rufca | Hospital Santa Casa de Ourinhos | Brazil
Dr. Uriel Rael Moreno Araujo | Hospital General 450 Durango | Mexico
Dr. Ruth Akiyo Mizoguchi | Chelsea and Westminster Hospital | UK
Nourah Alruwais | University of Sussex | UK

Special Thanks to the Organizing Committee:

We extend our heartfelt gratitude to the Chairpersons and Co-Chairpersons of Stroke 2024 and Vascular Dementia 2024, whose guidance and leadership were instrumental in curating a successful academic experience:

Chan Hong Park
Walter Bini
Xiu Liu
Walid Attia
Malini Narayanan
Muhammad Qazafi Memon
Ali Fahir Ozer
Anthony Hammond
Liz Karter
Pankaj Nishikant Surange
Giancarlo Guizzardi

Looking Ahead:

The success of Stroke 2024 has laid a strong foundation for future conferences, reinforcing the importance of continued global collaboration in the fight against neurological disorders and stroke. We look forward to welcoming you to the 14th International Conference on Neurological Disorders and Stroke, scheduled for November 17–18, 2025, in Paris, France, under the theme:

“Brain Health and Stroke: A Lifespan Approach”

Organizing committee members

Dr. Joel I. Osorio

CEO, Neurology

RegenerAge Clinic, Mexico

Radu Mutihac

Professor

Ecological University of Bucharest, Romania

Pat Quigley

Nurse consultant, Nurse Consultant, LLC

VISN 8 Patient Safety Center, USA

George Perry

Neuropathology

The University of Texas, USA

Dr. M. Raafat El-Gewely

Professor, Medical Biology

University of Tromsø, Norway

W S El MasrI

Managing Director

Midland Centre for Spinal Injuries, UK

Renowned Speakers

Dr. Edward Snowden

Doctor

American Autism Association, USA

Dr. Merlin Larson

Doctor

University of Salamanca, Spain

Dr. Robert Felix

Doctor

Anglia Ruskin University, UK

Prof. Annamaria Micheal

Professor

University of Foggia,, Italy

Dr. Julia Fagen

Professor

University of North Carolina School of Medicine,, USA

Dr. Richard Anderson

Professor

University of Ottawa, Canada

To Collaborate Scientific Professionals around the World

Conference Date	November 17-18, 2025
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Rajendra Badgaiyan

Chairman, Richmond University Medical Center, New York, USA.

I want to thank you sincerely for the outstanding conference you put together. It was more than I could have imagined and was simply astounding.Their presentations' ability to be both educational and motivating. I learnt a lot from the numerou